Search

everythinglearnresearchcommunity

for

Search:↓

Spironolactone helps reduce hospital visits and death from heart issues, lowers blood pressure, but has unclear effects on heart failure with normal heart pump function and can cause high potassium and breast enlargement in men.

Anabolic-androgenic steroids harm male hormone levels, sperm, metabolism, and can cause acne, hair loss, and breast growth.

Baricitinib helps with severe hair loss, negative-pressure therapy lowers hernia recurrence, tranexamic acid reduces bleeding, robot-assisted breast surgery may improve outcomes, and acellular dermal matrix could decrease breast reconstruction complications.

Pregnancy can cause normal skin changes, including darkening of certain areas, nail changes, vascular changes, and breast changes like stretch marks.

Higher BMI, IGF-1, and DHEAS levels are linked to advanced bone age in young Chinese girls with early breast development.

Certain skin diseases are linked to Agent Orange and similar chemicals; veterans should be screened and informed about uncertain risks, and current data doesn't link spironolactone with breast cancer.

Women with pituitary adenomas often have reproductive issues, like irregular periods and trouble getting pregnant, but not always breast milk production without pregnancy.

Estrogen-progestin contraception lowers ovarian, endometrial, and colon cancer risk but may raise breast and cervical cancer risk, helps with menstrual and acne issues, and new methods are as effective as pills. Metformin helps overweight women with PCOS and insulin resistance, and dopamine agonists treat prolactinomas.

Cooler scalp temperatures during chemotherapy may prevent hair loss.

Preventive measures and effective management are crucial for reducing skin side effects in cancer treatment.

Oral minoxidil effectively improves hair regrowth in cancer survivors with late alopecia.

Scalp cooling can effectively prevent hair loss during chemotherapy in pregnancy.

A rare type of skin cancer on the scalp can be mistaken for hair loss, causing delayed diagnosis and severe damage.

Reducing immunosuppression and using antiviral creams improved the woman's skin condition.

Chemotherapy caused hair loss with specific patterns, but most patients had hair regrowth after treatment, while some had lasting hair loss.

A woman kept her eyelashes during chemotherapy possibly because of her glaucoma eye drops.

Zinc supplements can help skin issues even if blood zinc levels are normal.

Rare ovarian tumors can cause hyperandrogenism, even if imaging appears normal.

Bilateral salpingo-oophorectomy resolved hyperandrogenism in a postmenopausal woman with rare ovarian tumors.

A rare ovarian tumor caused high testosterone in a postmenopausal woman, resolved by surgery.

A woman with rheumatoid arthritis had a unique type of scarring hair loss not caused by infection, requiring early treatment to avoid permanent hair loss.

Chemoprevention can significantly lower cancer risks and needs more research and collaboration.

The woman's widespread skin condition did not improve despite various treatments.

The new delivery system improved raloxifene's skin absorption and effectiveness against cancer cells.

The new drug delivery system improves exemestane's absorption and effectiveness.

Scalp cooling prevented hair loss in half of the patients, despite significant side effects.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Platelet-rich plasma therapy can increase FDG uptake in the scalp.

Most patients treated with trastuzumab and paclitaxel experience some hair loss, but it's usually not severe.

Topical calcitriol is safe for preventing hair loss during chemotherapy.